Association of a functional IRF7 variant with systemic lupus erythematosus - PubMed (original) (raw)
Jian Zhao, Xiaoxia Qian, Jonathan L H Wong, Kenneth M Kaufman, C Yung Yu; Hwee Siew Howe; Tan Tock Seng Hospital Lupus Study Group; Mo Yin Mok, John B Harley, Joel M Guthridge, Yeong Wook Song, Soo-Kyung Cho, Sang-Cheol Bae, Jennifer M Grossman, Bevra H Hahn, Frank C Arnett, Nan Shen, Betty P Tsao
Collaborators, Affiliations
- PMID: 21360504
- PMCID: PMC3063317
- DOI: 10.1002/art.30193
Association of a functional IRF7 variant with systemic lupus erythematosus
Qiong Fu et al. Arthritis Rheum. 2011 Mar.
Abstract
Objective: A previous genome-wide association study conducted in a population of European ancestry identified rs4963128, a KIAA1542 single-nucleotide polymorphism (SNP) 23 kb telomeric to IRF7 (the gene for interferon regulatory factor 7 [IRF-7]), to be strongly associated with systemic lupus erythematosus (SLE). This study was undertaken to investigate whether genetic polymorphism within IRF7 is a risk factor for the development of SLE.
Methods: We genotyped one KIAA1542 SNP (rs4963128) and one IRF7 SNP (rs1131665 [Q412R]) in an Asian population (1,302 cases, 1,479 controls), to assess their association with SLE. Subsequently, rs1131665 was further genotyped in independent panels of Chinese subjects (528 cases, 527 controls), European American subjects (446 cases, 461 controls), and African American subjects (159 cases, 115 controls) by TaqMan genotyping assay, to seek confirmation of association in various ethnic groups. A luciferase reporter assay was used to assess the effect of Q412R polymorphism on the activation of IRF-7.
Results: Consistent association of rs1131665 (Q412R) with SLE was identified in Asian, European American, and African American populations (total 2,435 cases and 2,582 controls) (P(meta) = 6.18 × 10(-6) , odds ratio 1.42 [95% confidence interval 1.22-1.65]). Expression of the IRF7 412Q risk allele resulted in a 2-fold increase in interferon-stimulated response element transcriptional activity compared with expression of IRF7 412R (P = 0.0003), suggesting that IRF7 412Q confers elevated IRF-7 activity and may therefore affect a downstream interferon pathway.
Conclusion: These findings show that the major allele of a nonsynonymous SNP, rs1131665 (412Q) in IRF7, confers elevated activation of IRF-7 and predisposes to the development of SLE in multiple ethnic groups. This result provides direct genetic evidence that IRF7 may be a risk gene for human SLE.
Copyright © 2011 by the American College of Rheumatology.
Figures
Figure 1
Schematic structure of IRF7. A, Genomic structure of KIAA1542-IRF7 locus. Two KIAA1542 SNPs, rs4963128 and rs702966, are 23kb and 0.6kb telomeric to IRF7, respectively. In HapMap datasets (CEU, YRI, CHB and JPT), rs702966 is in strong LD (r2=1) with multiple SNPs in IRF7. B, Transcript structure of IRF7 isoform a. rs1131665 (Q412R) is highlighted. C, Conservative domain in IRF7 protein. DBD: DNA binding domain; CAD: constitutive activation domain; VAD: virus-activated domain; ID: inhibitory domain; SRD: signal response domain.
Figure 2
Functional analysis of Q412R polymorphism. A, Protein sequence alignment of IRF7. The multiple sequence alignment of the IRF7 protein homologs was performed using MUSCLE. Q412R is highlighted. B, 3D structure prediction of IRF7 protein. Left panel: 412Q; right panel: 412R. The Q412R is depicted in blue and the nearby amino acids 459R, 407F and 429Y in plum. The contacts between Q412R and other amino acids are represented by red lines. R shows much more contacts with these amino acids as compared to Q. C, Q412R regulates IRF7 activity in vitro. ISRE reporter plasmid was co-transfected with either IRF7 412Q or 412R vector to HEK293 cells, and relative ISRE luciferase activity was measured after 24 hours. Expression of IRF7 412Q resulted in a 2-fold increase in ISRE transcriptional activity compared with that of IRF7 412R.
Comment in
- Association between functional IRF7 variant and systemic lupus erythematosus may need more critical examination: comment on the article by Fu et al.
Wang F, Zou YF, Sun GP. Wang F, et al. Arthritis Rheum. 2011 Oct;63(10):3177-8; author reply 3178-9. doi: 10.1002/art.30519. Arthritis Rheum. 2011. PMID: 21739418 No abstract available.
Similar articles
- Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.
Salloum R, Franek BS, Kariuki SN, Rhee L, Mikolaitis RA, Jolly M, Utset TO, Niewold TB. Salloum R, et al. Arthritis Rheum. 2010 Feb;62(2):553-61. doi: 10.1002/art.27182. Arthritis Rheum. 2010. PMID: 20112359 Free PMC article. - Association of PHRF1-IRF7 region polymorphism with clinical manifestations of systemic lupus erythematosus in a Japanese population.
Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, Matsumoto I, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N. Kawasaki A, et al. Lupus. 2012 Jul;21(8):890-5. doi: 10.1177/0961203312439333. Epub 2012 Mar 20. Lupus. 2012. PMID: 22433914 - The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus.
Lin LH, Ling P, Liu MF. Lin LH, et al. J Rheumatol. 2011 Sep;38(9):1914-9. doi: 10.3899/jrheum.101004. Epub 2011 Jun 1. J Rheumatol. 2011. PMID: 21632682 - The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus.
Lewis MJ, Jawad AS. Lewis MJ, et al. Rheumatology (Oxford). 2017 Apr 1;56(suppl_1):i67-i77. doi: 10.1093/rheumatology/kew399. Rheumatology (Oxford). 2017. PMID: 27940583 Review. - The miR-146a polymorphism and susceptibility to systemic lupus erythematosus and rheumatoid arthritis : a meta-analysis.
Lee YH, Bae SC. Lee YH, et al. Z Rheumatol. 2015 Mar;74(2):153-6. doi: 10.1007/s00393-014-1509-6. Z Rheumatol. 2015. PMID: 25349113 Review.
Cited by
- Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19.
Nln I, Fernandez-Ruiz R, Muskardin TLW, Paredes JL, Blazer AD, Tuminello S, Attur M, Iturrate E, Petrilli CM, Abramson SB, Chakravarti A, Niewold TB. Nln I, et al. Transl Res. 2022 Jun;244:47-55. doi: 10.1016/j.trsl.2022.01.007. Epub 2022 Jan 31. Transl Res. 2022. PMID: 35114420 Free PMC article. - Differential regulation of the interferon response in systemic lupus erythematosus distinguishes patients of Asian ancestry.
Rector I, Owen KA, Bachali P, Hubbard E, Yazdany J, Dall'era M, Grammer AC, Lipsky PE. Rector I, et al. RMD Open. 2023 Sep;9(3):e003475. doi: 10.1136/rmdopen-2023-003475. RMD Open. 2023. PMID: 37709528 Free PMC article. - Type I interferon in rheumatic diseases.
Muskardin TLW, Niewold TB. Muskardin TLW, et al. Nat Rev Rheumatol. 2018 Mar 21;14(4):214-228. doi: 10.1038/nrrheum.2018.31. Nat Rev Rheumatol. 2018. PMID: 29559718 Free PMC article. Review. - Modeling of horizontal pleiotropy identifies possible causal gene expression in systemic lupus erythematosus.
Chepelev I, Harley ITW, Harley JB. Chepelev I, et al. Front Lupus. 2023;1:1234578. doi: 10.3389/flupu.2023.1234578. Epub 2023 Oct 3. Front Lupus. 2023. PMID: 37799268 Free PMC article. - Type I Interferons in Systemic Autoimmune Rheumatic Diseases: Pathogenesis, Clinical Features and Treatment Options.
Drougkas K, Skarlis C, Mavragani C. Drougkas K, et al. Mediterr J Rheumatol. 2024 Jun 30;35(Suppl 2):365-380. doi: 10.31138/mjr.270324.tis. eCollection 2024 Jun. Mediterr J Rheumatol. 2024. PMID: 39193187 Free PMC article. Review.
References
- Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 2005;434:772–777. - PubMed
- Crow MK. Collaboration, Genetic Associations, and Lupus Erythematosus. N Engl J Med. 2008;358:956–961. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01AR62277/AR/NIAMS NIH HHS/United States
- P30 GM103510/GM/NIGMS NIH HHS/United States
- AI-083194/AI/NIAID NIH HHS/United States
- P30 AR053483/AR/NIAMS NIH HHS/United States
- R01 AR043814-13/AR/NIAMS NIH HHS/United States
- AR-054459/AR/NIAMS NIH HHS/United States
- AI-24717/AI/NIAID NIH HHS/United States
- N01-AR-062277/AR/NIAMS NIH HHS/United States
- R01 AR043814-12/AR/NIAMS NIH HHS/United States
- R01 AR054459/AR/NIAMS NIH HHS/United States
- RR-015577/RR/NCRR NIH HHS/United States
- AR-049084/AR/NIAMS NIH HHS/United States
- AR-053483/AR/NIAMS NIH HHS/United States
- P01 AI083194/AI/NIAID NIH HHS/United States
- P01 AR049084/AR/NIAMS NIH HHS/United States
- AR-043814/AR/NIAMS NIH HHS/United States
- P20 RR015577/RR/NCRR NIH HHS/United States
- P30 RR031152/RR/NCRR NIH HHS/United States
- AR-42460/AR/NIAMS NIH HHS/United States
- R01 AR043814/AR/NIAMS NIH HHS/United States
- R37 AI024717/AI/NIAID NIH HHS/United States
- R01 AR042460/AR/NIAMS NIH HHS/United States
- R01 AI024717/AI/NIAID NIH HHS/United States
- RR-020193/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical